These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38401227)

  • 1. Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis.
    Hjort A; Iggman D; Rosqvist F
    Clin Nutr; 2024 Apr; 43(4):915-925. PubMed ID: 38401227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
    Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics?
    Zahalka SJ; Galindo RJ; Shah VN; Low Wang CC
    J Diabetes Sci Technol; 2024 Jul; 18(4):835-846. PubMed ID: 38629784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Physical Activity on Glycemic Variability Assessed by Continuous Glucose Monitoring in Patients With Type 2 Diabetes Mellitus: A Systematic Review.
    Bennetsen SL; Feineis CS; Legaard GE; Lyngbæk MPP; Karstoft K; Ried-Larsen M
    Front Endocrinol (Lausanne); 2020; 11():486. PubMed ID: 32903679
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic peripheral neuropathy and glycemic variability assessed by continuous glucose monitoring: A systematic review and meta-analysis.
    Jia Y; Long D; Yang Y; Wang Q; Wu Q; Zhang Q
    Diabetes Res Clin Pract; 2024 Jul; 213():111757. PubMed ID: 38944250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (Pre)diabetes, glycemia, and daily glucose variability are associated with retinal nerve fiber layer thickness in The Maastricht Study.
    van der Heide FCT; Foreman YD; Franken IWM; Henry RMA; Kroon AA; Dagnelie PC; Eussen SJPM; Berendschot TTJM; Schouten JSAG; Webers CAB; Schram MT; van der Kallen CJH; van Greevenbroek MMJ; Wesselius A; Schalkwijk CG; Schaper NC; Brouwers MCGJ; Stehouwer CDA
    Sci Rep; 2022 Oct; 12(1):17750. PubMed ID: 36273238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
    Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
    Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literature.
    Salkind SJ; Huizenga R; Fonda SJ; Walker MS; Vigersky RA
    J Diabetes Sci Technol; 2014 Sep; 8(5):1042-7. PubMed ID: 24876453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.
    Seidu S; Kunutsor SK; Ajjan RA; Choudhary P
    Diabetes Care; 2024 Jan; 47(1):169-179. PubMed ID: 38117991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
    Reed J; Dong T; Eaton E; Friswold J; Porges J; Al-Kindi SG; Rajagopalan S; Neeland IJ
    Diabetes Obes Metab; 2024 Jul; 26(7):2881-2889. PubMed ID: 38680050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
    Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT
    Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with nocturnal and diurnal glycemic variability in patients with type 2 diabetes: a cross-sectional study.
    Jiang J; Xia Z; Zheng D; Li Y; Li F; Wang W; Ding S; Zhang J; Su X; Zhai Q; Zuo Y; Zhang Y; Gaisano HY; He Y; Sun J
    J Endocrinol Invest; 2024 Jan; 47(1):245-253. PubMed ID: 37354249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data.
    Kohnert KD; Heinke P; Fritzsche G; Vogt L; Augstein P; Salzsieder E
    Diabetes Technol Ther; 2013 Jun; 15(6):448-54. PubMed ID: 23550553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data.
    Acciaroli G; Sparacino G; Hakaste L; Facchinetti A; Di Nunzio GM; Palombit A; Tuomi T; Gabriel R; Aranda J; Vega S; Cobelli C
    J Diabetes Sci Technol; 2018 Jan; 12(1):105-113. PubMed ID: 28569077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.
    Breyton AE; Lambert-Porcheron S; Laville M; Vinoy S; Nazare JA
    Front Endocrinol (Lausanne); 2021; 12():666008. PubMed ID: 34566883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic health tracking using Ultrahuman M1 continuous glucose monitoring platform in non- and pre-diabetic Indians: a multi-armed observational study.
    Chaudhry M; Kumar M; Singhal V; Srinivasan B
    Sci Rep; 2024 Mar; 14(1):6490. PubMed ID: 38499685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between glycaemic variability and cardiovascular autonomic dysfunction in patients with type 1 diabetes: A systematic review.
    Helleputte S; De Backer T; Lapauw B; Shadid S; Celie B; Van Eetvelde B; Vanden Wyngaert K; Calders P
    Diabetes Metab Res Rev; 2020 Jul; 36(5):e3301. PubMed ID: 32073212
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.